6Inui A. Cancer anorexia- cachexia syndrome: current issues in re-search and management [J]. CA Cancer J Clin,2002,52(2) :72 - 91.
7Femial RA, Goyette RE. The science of megestrol acetate delivery potential to improve outcomes in cachexia [J]. Bio Drugs,2005,19(3) :179- 187.
8Maltoni M, Namli O, Scarpi E, et al. High - dose progestins for the treatment of cancer anorexia - cachexia syndrome: a systematic review of randomised clinical trials [J]. Ann Oncol,2001,12(3) :289 - 300.
9Jatoi A, Rowland K, Loprinzi CL, et al. An deosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer - associated wasting: a North Centre' Cancer Treatment Group and National Cancer Institute of Canada collaborative effort [ J ]. J Clin Oncol,2004,22(12) :2469 - 2476.
10Kumar S, Kishimoto H, Chua HL, et al. lntedeukin - 1 alpha promotes tumor growth and cachexia in MCF - 7 xenograft model of breast cancer [J]. AJP,2003,163(6) :2531 - 2541.
